Published in Neth Heart J on March 01, 2010
The NHJ 2012 in retrospect: which articles are cited most? Neth Heart J (2012) 1.02
Assessment of left ventricular function: visual or quantitative? Int J Cardiovasc Imaging (2010) 0.86
Assessment of left ventricular volumes; reliable by gated SPECT? Int J Cardiovasc Imaging (2010) 0.84
Evaluation of hypertrophic cardiomyopathy: new horizons for CMR? Neth Heart J (2010) 0.81
Speckle tracking: distinction of physiologic from pathologic LVH? Int J Cardiovasc Imaging (2010) 0.78
The tale of the three sisters. Neth Heart J (2010) 0.75
CMR-determined scar volume: predictive for ventricular tachycardias? Int J Cardiovasc Imaging (2011) 0.75
Left ventricular mass assessment by CMR; how to define the optimal index. Int J Cardiovasc Imaging (2010) 0.75
Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J (2001) 8.90
Long-term safety and effectiveness of iron-chelation therapy with deferiprone for thalassemia major. N Engl J Med (1998) 6.86
Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J (2007) 6.34
Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation (2005) 5.85
Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J (2005) 4.62
Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. J Am Coll Cardiol (2008) 4.51
Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol (2003) 4.36
An atypical variant of Fabry's disease in men with left ventricular hypertrophy. N Engl J Med (1995) 3.42
Tissue Doppler imaging consistently detects myocardial abnormalities in patients with hypertrophic cardiomyopathy and provides a novel means for an early diagnosis before and independently of hypertrophy. Circulation (2001) 3.33
Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy. Circulation (2002) 3.22
Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol (2002) 3.14
Sudden death in young athletes. Circulation (1980) 3.05
Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. J Am Coll Cardiol (2000) 2.89
The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement. QJM (1998) 2.81
Redefinition of uremic cardiomyopathy by contrast-enhanced cardiac magnetic resonance imaging. Kidney Int (2006) 2.80
Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis. Radiology (2007) 2.79
Delayed contrast enhancement of MRI in hypertrophic cardiomyopathy. Magn Reson Imaging (2004) 2.58
Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy. Circulation (2005) 2.35
The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol (2004) 2.31
Cardiovascular magnetic resonance and prognosis in cardiac amyloidosis. J Cardiovasc Magn Reson (2008) 2.01
The prognostic importance of left ventricular geometry in uremic cardiomyopathy. J Am Soc Nephrol (1995) 2.00
Diastolic dysfunction is associated with altered myocardial metabolism in asymptomatic normotensive patients with well-controlled type 2 diabetes mellitus. J Am Coll Cardiol (2003) 1.80
Cardiac magnetic resonance imaging of eosinophilic endomyocardial disease. Int J Cardiol (2007) 1.75
Disease penetrance and risk stratification for sudden cardiac death in asymptomatic hypertrophic cardiomyopathy mutation carriers. Eur Heart J (2009) 1.73
Noninvasive diagnosis of biopsy-proven cardiac amyloidosis. J Am Coll Cardiol (2004) 1.70
Diastolic abnormalities as the first feature of hypertrophic cardiomyopathy in Dutch myosin-binding protein C founder mutations. JACC Cardiovasc Imaging (2009) 1.70
Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease. Heart (2000) 1.66
Structural abnormalities of the inferoseptal left ventricular wall detected by cardiac magnetic resonance imaging in carriers of hypertrophic cardiomyopathy mutations. J Am Coll Cardiol (2006) 1.63
Myocardial strain and torsion quantified by cardiovascular magnetic resonance tissue tagging: studies in normal and impaired left ventricular function. J Am Coll Cardiol (2006) 1.59
Diabetic cardiomyopathy and subclinical cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis (MESA). Diabetes Care (2006) 1.40
Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in light-chain cardiac amyloidosis. Am J Cardiol (2008) 1.31
Paradoxical increase in ventricular torsion and systolic torsion rate in type I diabetic patients under tight glycemic control. J Am Coll Cardiol (2005) 1.25
Long-term survival (10 years or more) in 30 patients with primary amyloidosis. Blood (1999) 1.24
Metabolic disturbances in diabetic cardiomyopathy. Mol Cell Biochem (1998) 1.22
Three-dimensional assessment of left ventricular systolic strain in patients with type 2 diabetes mellitus, diastolic dysfunction, and normal ejection fraction. Am J Cardiol (2004) 1.18
The histological basis of late gadolinium enhancement cardiovascular magnetic resonance in a patient with Anderson-Fabry disease. J Cardiovasc Magn Reson (2006) 1.12
A comparison of magnetic resonance imaging and cardiac biopsy in the evaluation of heart iron overload in patients with beta-thalassemia major. Eur J Haematol (2005) 1.05
Amyloidosis and cardiac involvement. Ann Med Interne (Paris) (2000) 1.04
Echocardiographic abnormalities in patients with transfusion-dependent anemia and secondary myocardial iron deposition. Am J Med (1978) 1.03
Feasibility of tissue magnetic resonance imaging: a pilot study in comparison with tissue Doppler imaging and invasive measurement. J Am Coll Cardiol (2005) 1.02
Clefts can be seen in the basal inferior wall of the left ventricle and the interventricular septum in healthy volunteers as well as patients by cardiovascular magnetic resonance. J Am Coll Cardiol (2007) 0.96
Assessment of diastolic function by cardiovascular magnetic resonance. Am Heart J (2002) 0.95
Differentiation of athlete's heart from pathological forms of cardiac hypertrophy by means of geometric indices derived from cardiovascular magnetic resonance. J Cardiovasc Magn Reson (2005) 0.86
Diastolic dysfunction and abnormality of the Na+/Ca2+ exchanger in single uremic cardiac myocytes. Kidney Int (2006) 0.84
Delayed contrast enhancement and perfusable tissue index in hypertrophic cardiomyopathy: comparison between cardiac MRI and PET. J Nucl Med (2005) 0.82
Structural abnormalities of the left ventricle in hypertrophic cardiomyopathy mutation carriers detectable before the development of hypertrophy. Neth Heart J (2007) 0.81
Images in cardiovascular medicine. Prominent crypt formation in the inferoseptum of a hypertrophic cardiomyopathy mutation carrier mimics noncompaction cardiomyopathy. Circulation (2007) 0.77
Quantification of regional contractile function after infarction: strain analysis superior to wall thickening analysis in discriminating infarct from remote myocardium. J Am Coll Cardiol (2001) 1.73
Magnetic resonance angiography of anomalous coronary arteries. A new gold standard for delineating the proximal course? Circulation (1995) 1.53
Intramyocardial hemorrhage and microvascular obstruction after primary percutaneous coronary intervention. Int J Cardiovasc Imaging (2009) 1.47
[Heart tamponade: a life-threatening complication of a central venous catheter]. Ned Tijdschr Geneeskd (1997) 1.39
Timing of cardiac contraction in humans mapped by high-temporal-resolution MRI tagging: early onset and late peak of shortening in lateral wall. Am J Physiol Heart Circ Physiol (2004) 1.27
Bone marrow cell therapy after acute myocardial infarction: the HEBE trial in perspective, first results. Neth Heart J (2008) 1.16
Modeling the emergency cardiac in-patient flow: an application of queuing theory. Health Care Manag Sci (2007) 1.14
Magnetic resonance imaging, pacemakers and implantable cardioverter-defibrillators: current situation and clinical perspective. Neth Heart J (2010) 1.11
Acute, subacute, and chronic myocardial infarction: quantitative analysis of gadolinium-enhanced MR images. Radiology (1991) 1.10
Single coronary artery: morphological and functional evaluation by magnetic resonance imaging. Eur Heart J (1995) 1.06
Quantification of global left ventricular function: comparison of multidetector computed tomography and magnetic resonance imaging. a meta-analysis and review of the current literature. Acta Radiol (2006) 1.04
'No-reflow' after acute myocardial infarction: direct visualisation of microvascular obstruction by gadolinium-enhanced CMR. Neth Heart J (2008) 1.03
Cardiac PET-CT: advanced hybrid imaging for the detection of coronary artery disease. Neth Heart J (2010) 1.03
MRI and cardiac implantable electronic devices; current status and required safety conditions. Neth Heart J (2014) 1.03
Reperfused and nonreperfused myocardial infarction: diagnostic potential of Gd-DTPA--enhanced MR imaging. Radiology (1989) 1.01
Improved harmonic phase myocardial strain maps. Magn Reson Med (2001) 1.00
Three-dimensional respiratory-gated MR angiography of coronary arteries: comparison with conventional coronary angiography. AJR Am J Roentgenol (1996) 0.97
Assessment of left ventricular ejection fraction in patients eligible for ICD therapy: Discrepancy between cardiac magnetic resonance imaging and 2D echocardiography. Neth Heart J (2014) 0.97
Magnetic resonance imaging of regional myocardial perfusion in patients with single-vessel coronary artery disease: quantitative comparison with (201)Thallium-SPECT and coronary angiography. J Magn Reson Imaging (2000) 0.95
Quadricuspid pulmonary valve and left pulmonary artery aneurysm in an asymptomatic patient assessed by cardiovascular MRI. Neth Heart J (2013) 0.95
ENerGetIcs in hypertrophic cardiomyopathy: traNslation between MRI, PET and cardiac myofilament function (ENGINE study). Neth Heart J (2013) 0.94
MRI of coronary arteries: 2D breath-hold vs 3D respiratory-gated acquisition. J Comput Assist Tomogr (1995) 0.93
In vivo validation of magnetic resonance blood volume flow measurements with limited spatial resolution in small vessels. Magn Reson Med (1995) 0.93
Protocol for two-dimensional magnetic resonance coronary angiography studied in three-dimensional magnetic resonance data sets. Am Heart J (1995) 0.92
Angina pectoris due to left main coronary artery compression in Eisenmenger ductus arteriosus. Am Heart J (1993) 0.92
Regional timing of myocardial shortening is related to prestretch from atrial contraction: assessment by high temporal resolution MRI tagging in humans. Am J Physiol Heart Circ Physiol (2004) 0.92
Towards a noninvasive anatomical and functional diagnostic work-up of patients with suspected coronary artery disease. Neth Heart J (2010) 0.90
Transesophageal echocardiography and magnetic resonance imaging for the assessment of saccular aneurysm of the transverse thoracic aorta. Int J Cardiol (1991) 0.89
Assessment of flow in the right human coronary artery by magnetic resonance phase contrast velocity measurement: effects of cardiac and respiratory motion. Magn Reson Med (1996) 0.87
Cardiac magnetic resonance imaging: artefacts for clinicians. Neth Heart J (2014) 0.87
Safety of gadoversetamide in patients with acute and chronic myocardial infarction. J Magn Reson Imaging (2008) 0.86
Three-dimensional myocardial strain analysis based on short- and long-axis magnetic resonance tagged images using a 1D displacement field. Magn Reson Imaging (2000) 0.86
Double orifice mitral valve visualized on echocardiography and MRI. Neth Heart J (2012) 0.86
Intracoronary infusion of mononuclear cells after PCI-treated myocardial infarction and arrhythmogenesis: is it safe? Neth Heart J (2012) 0.86
Semiquantitation of regional myocardial blood flow in normal human subjects by first-pass magnetic resonance imaging. Am Heart J (1995) 0.85
Clinical utility of two-dimensional magnetic resonance angiography in detecting coronary artery disease. Eur Heart J (1997) 0.85
Feasibility of cardiovascular magnetic resonance of angiographically diagnosed congenital solitary coronary artery fistulas in adults. J Cardiovasc Magn Reson (2007) 0.83
Assessment of acute myocardial infarction in man with magnetic resonance imaging and the use of a new paramagnetic contrast agent gadolinium-BOPTA. Magn Reson Imaging (1996) 0.83
Lipomatous metaplasia in myocardial infarction detected by cardiovascular magnetic resonance. Heart (2006) 0.83
Potential of [11C]acetate for measuring myocardial blood flow: Studies in normal subjects and patients with hypertrophic cardiomyopathy. J Nucl Cardiol (2009) 0.82
Recognition of infarct localization by specific changes in intramural myocardial mechanics. Am Heart J (1999) 0.82
Reduction of infarct size by intravenous injection of uncultured adipose derived stromal cells in a rat model is dependent on the time point of application. Stem Cell Res (2011) 0.82
Nontriggered magnetic resonance velocity measurement of the time-average of pulsatile velocity. Magn Reson Med (1993) 0.82
A brief cognitive-behavioral intervention for treating depression and panic disorder in patients with noncardiac chest pain: a 24-week randomized controlled trial. Depress Anxiety (2013) 0.81
Value of magnetic resonance imaging in assessing patency and function of coronary artery bypass grafts. An angiographically controlled study. Circulation (1996) 0.81
Structural abnormalities of the left ventricle in hypertrophic cardiomyopathy mutation carriers detectable before the development of hypertrophy. Neth Heart J (2007) 0.81
Rapid formation of collateral arteries in a neonate with interruption of the aortic arch. Cardiol Young (2001) 0.80
Aetiology and resistance patterns of community-acquired pneumonia in León, Nicaragua. Int J Antimicrob Agents (2006) 0.80
The multidrug resistance protein breast cancer resistance protein (BCRP) protects adipose-derived stem cells against ischemic damage. Cell Biol Toxicol (2012) 0.79
[Hypertrophic cardiomyopathy: a genetically-carried heart disease]. Ned Tijdschr Geneeskd (2002) 0.79
Magnetic resonance imaging of myocardial perfusion in single-vessel coronary artery disease: implications for transmural assessment of myocardial perfusion. J Cardiovasc Magn Reson (2000) 0.79
New insights in LV torsion for the selection of cardiac resynchronisation therapy candidates. Neth Heart J (2011) 0.78
Carbon-fiber electrodes and leads for electrocardiography during MR imaging. Radiology (1989) 0.78
Ultrasound and microbubble-targeted delivery of therapeutic compounds: ICIN Report Project 49: Drug and gene delivery through ultrasound and microbubbles. Neth Heart J (2009) 0.77
Myocardial perfusion imaging: clinical experience and recent progress in radionuclide scintigraphy and magnetic resonance imaging. Int J Card Imaging (1997) 0.77
Variance components of two-dimensional strain parameters in the left-ventricular heart wall obtained by magnetic resonance tagging. Int J Cardiovasc Imaging (2001) 0.77
Striking left atrial enlargement as a consequence of mitral valve disease. Eur Heart J (2005) 0.77
Simultaneous MRI tagging and through-plane velocity quantification: a three-dimensional myocardial motion tracking algorithm. J Magn Reson Imaging (1999) 0.76
The impact of obesity on the relationship between epicardial adipose tissue, left ventricular mass and coronary microvascular function. Eur J Nucl Med Mol Imaging (2015) 0.76
Magnetic resonance imaging of the pulmonary venous flow pattern in mitral regurgitation. Independence of the investigated vein. Eur Heart J (1995) 0.75
Transesophageal cardiac pacing during magnetic resonance imaging: feasibility and safety considerations. Magn Reson Med (1996) 0.75
Double aortic arch. Neth Heart J (2007) 0.75
Coronary anomaly diagnosed by computed tomography coronary angiography in a patient with atypical chest pain. Neth Heart J (2011) 0.75
Traumatic myocardial infarction visualised by computed tomography angiography. Neth Heart J (2012) 0.75
Magnetic resonance imaging of cardiac anatomy. A standard procedure. Eur J Radiol (1987) 0.75
A jellyfish thrombus. Heart Lung Circ (2011) 0.75
Quantification of coronary artery bypass graft flow by magnetic resonance phase velocity mapping. Magn Reson Imaging (1996) 0.75
Gadolinium-enhanced magnetic resonance imaging in acute myocardial infarction. Eur J Radiol (1990) 0.75
Atrial fibrillation: an unusual cause. Neth Heart J (2008) 0.75
One coronary artery, three abnormalities. Neth Heart J (2014) 0.75
Simultaneous noninvasive measurement of blood flow in the great cardiac vein and left anterior descending artery. J Cardiovasc Magn Reson (2001) 0.75
Images in cardiology: Transient pericardial effusion after cardiac surgery: often unrecognised. Heart (2005) 0.75
Congenital absence of the pericardium. Neth Heart J (2011) 0.75
Myocardial viability by contrast enhanced MRI in a patient with left bundle branch block showing a severe defect on FDG-PET. Heart (2002) 0.75
[Not Available]. Neth Heart J (2011) 0.75